The FDA has granted breakthrough therapy designation to privosegtor for optic neuritis, a common symptom of multiple ...

Glaucoma is a blinding disease caused by damage to the optic nerve, leading to permanent vision loss. The main risk factor is ...

Breakthrough therapy designation granted as Company advances the PIONEER registrational program in optic neuropathies to create a potential ...

Privosegtor is advancing in the registrational PIONEER program across 2 key optic neuropathies, representing an unaddressed potential market of $7 billion in the U.S. Privosegtor achieved an average ...

The US Food and Drug Administration has granted breakthrough therapy designation to Oculis’ neuroprotective candidate ...

Treatment for optic nerve cupping takes many different forms depending on the severity of the disease and the factors that originally caused the optic nerve damage. Research will lead to future ...

A 30-year-old woman was referred to the New England Eye Center neuro-ophthalmology service for evaluation of bilateral optic disc swelling found incidentally during her annual eye examination. Her ...

A novel treatment for Leber's Hereditary Optic Neuropathy (LHON), a rare genetic disease that can lead to sudden loss of vision, has been approved for NHS patients following a successful clinical ...

Scientists are investigating new ways to provide visual signals to the blind by directly stimulating the optic nerve. Their preliminary study uses a new type of neural electrode and provides distinct ...